GAO: Prior Authorization For Medicare Imaging Scans Should Be On The Table
This article was originally published in The Pink Sheet Daily
Executive Summary
Preapproval won’t work for CMS the way it does in the private sector, and other curbs are in place, stakeholders retort.
You may also be interested in...
CMS Urged To Cover Beta Amyloid PET Scans For Alzheimer's, But Cautiously
Imaging stakeholders call for Medicare coverage of beta amyloid positron emission tomography scans to help diagnose and manage dementia patients, but clinical societies warn against using the technology as a screening tool for Alzheimer’s disease. CMS took comments through Nov. 8 on its ongoing national coverage analysis.
French Firm Explores U.S. Regulatory Strategy For Blood-based Alzheimer’s Test
With a CE mark in hand, Exonhit is training its sights on the U.S. market. A 160-patient pilot study conducted through the Cleveland Clinic completed enrollment a few weeks ago.
Clarity Over Health Care Reform Boosts Telehealth Prospects
Accountable care organizations and the Center for Medicare and Medicaid Innovation are driving growth in telemedicine.